Terbutaline Sulfate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00871 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 29 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | obstructive lung disease | KG + DL |
| 2 | respiratory malformation | KG + DL |
| 3 | Rienhoff syndrome | KG + DL |
| 4 | laryngotracheitis | KG + DL |
| 5 | bronchial neoplasm (disease) | KG + DL |
| 6 | chronic obstructive pulmonary disease | KG + DL |
| 7 | anaphylaxis | KG + DL |
| 8 | food-dependent exercise-induced anaphylaxis | KG + DL |
| 9 | nasolacrimal duct disease | KG + DL |
| 10 | eversion of lacrimal punctum | KG + DL |
| 11 | secretory apparatus of the lacrimal system anomaly | KG + DL |
| 12 | lacrimal atrophy | KG + DL |
| 13 | stenosis of lacrimal sac | KG + DL |
| 14 | lacrimal passage granuloma | KG + DL |
| 15 | disorder of lacrimal gland | KG + DL |
| 16 | anomaly of the secretory and excretory apparatus of the lacrimal system | KG + DL |
| 17 | excretory apparatus of the lacrimal system anomaly | KG + DL |
| 18 | excessive tearing | KG + DL |
| 19 | tracheal disease | KG + DL |
| 20 | tracheal stenosis | KG + DL |
| 21 | compensatory emphysema | KG + DL |
| 22 | hyperlucent lung | KG + DL |
| 23 | interstitial emphysema | KG + DL |
| 24 | congenital lobar emphysema | KG + DL |
| 25 | susceptibility to respiratory infections associated with CD8alpha chain mutation | KG + DL |
| 26 | brain aneurysm | KG + DL |
| 27 | COPD, severe early onset | KG + DL |
| 28 | tracheal calcification | KG + DL |
| 29 | anorectal stricture | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.